We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UiPath Stock Appears Undervalued Based on Forward P/S Ratio
Read MoreHide Full Article
Key Takeaways
PATH trades at a 4.37x forward P/S, below 5.68x of the industry average, suggesting relative undervaluation.
Strong recurring revenues, global expansion and AI integrations support PATH's enterprise momentum.
PATH's valuation trails peers like NOW and PEGA, despite faster growth and a focused automation strategy.
UiPath Inc. (PATH - Free Report) appears attractively valued compared with its industry peers based on the forward 12-month price-to-sales (P/S) ratio. Currently trading at 4.37x, PATH’s valuation falls short of the industry average of 5.68x, suggesting the stock may offer a relative bargain for growth-focused investors. As a leader in robotic process automation, UiPath has continued to expand its enterprise footprint, with growing adoption across finance, healthcare and logistics sectors.
Image Source: Zacks Investment Research
Despite macroeconomic uncertainty, the company has maintained solid top-line performance, driven by a combination of strong recurring revenues and international expansion. The lower P/S ratio reflects market caution, possibly tied to concerns about profitability or broader tech-sector volatility. However, for long-term investors, PATH’s product breadth, developer ecosystem and recurring revenue model could warrant a re-evaluation of its current discounted valuation.
The company's investments in AI-powered automation and integrations with major platforms like Microsoft and SAP enhance its long-term relevance. As digital transformation continues to be a strategic priority for enterprises, UiPath remains well-positioned to benefit from secular demand trends, even if short-term sentiment remains cautious.
PATH vs. Peers: Valuation and Market Position
Compared with peers like ServiceNow (NOW - Free Report) and Pegasystems (PEGA - Free Report) , UiPath’s valuation looks modest. ServiceNow trades at a significantly higher forward P/S multiple due to its broad enterprise suite and consistent profitability. Still, PATH’s 4.37x ratio offers a more accessible entry point for investors seeking RPA exposure.
Image Source: Zacks Investment Research
Pegasystems, another player in the automation and customer engagement software space, also trades at a higher P/S ratio than PATH. While PEGA benefits from strong client relationships, PATH’s faster revenue growth and deeper automation focus could support stronger long-term upside, highlighting its relative value in the enterprise software landscape.
Image: Bigstock
UiPath Stock Appears Undervalued Based on Forward P/S Ratio
Key Takeaways
UiPath Inc. (PATH - Free Report) appears attractively valued compared with its industry peers based on the forward 12-month price-to-sales (P/S) ratio. Currently trading at 4.37x, PATH’s valuation falls short of the industry average of 5.68x, suggesting the stock may offer a relative bargain for growth-focused investors. As a leader in robotic process automation, UiPath has continued to expand its enterprise footprint, with growing adoption across finance, healthcare and logistics sectors.
Despite macroeconomic uncertainty, the company has maintained solid top-line performance, driven by a combination of strong recurring revenues and international expansion. The lower P/S ratio reflects market caution, possibly tied to concerns about profitability or broader tech-sector volatility. However, for long-term investors, PATH’s product breadth, developer ecosystem and recurring revenue model could warrant a re-evaluation of its current discounted valuation.
The company's investments in AI-powered automation and integrations with major platforms like Microsoft and SAP enhance its long-term relevance. As digital transformation continues to be a strategic priority for enterprises, UiPath remains well-positioned to benefit from secular demand trends, even if short-term sentiment remains cautious.
PATH vs. Peers: Valuation and Market Position
Compared with peers like ServiceNow (NOW - Free Report) and Pegasystems (PEGA - Free Report) , UiPath’s valuation looks modest. ServiceNow trades at a significantly higher forward P/S multiple due to its broad enterprise suite and consistent profitability. Still, PATH’s 4.37x ratio offers a more accessible entry point for investors seeking RPA exposure.
Pegasystems, another player in the automation and customer engagement software space, also trades at a higher P/S ratio than PATH. While PEGA benefits from strong client relationships, PATH’s faster revenue growth and deeper automation focus could support stronger long-term upside, highlighting its relative value in the enterprise software landscape.
PATH currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.